Dang Shangyu, Wu Shenjie, Wang Jiawei, Li Hongbo, Huang Min, He Wei, Li Yue-Ming, Wong Catherine C L, Shi Yigong
Ministry of Education Key Laboratory of Protein Science, Tsinghua-Peking Joint Center for Life Sciences, Center for Structural Biology, and.
State Key Laboratory of Bio-membrane and Membrane Biotechnology, School of Life Sciences and School of Medicine, Tsinghua University, Beijing 100084, China;
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3344-9. doi: 10.1073/pnas.1502150112. Epub 2015 Mar 2.
Aberrant cleavage of amyloid precursor protein (APP) by γ-secretase contributes to the development of Alzheimer's disease. More than 200 disease-derived mutations have been identified in presenilin (the catalytic subunit of γ-secretase), making modulation of γ-secretase activity a potentially attractive therapeutic opportunity. Unfortunately, the technical challenges in dealing with intact γ-secretase have hindered discovery of modulators and demand a convenient substitute approach. Here we report that, similar to γ-secretase, the archaeal presenilin homolog PSH faithfully processes the substrate APP C99 into Aβ42, Aβ40, and Aβ38. The molar ratio of the cleavage products Aβ42 over Aβ40 by PSH is nearly identical to that by γ-secretase. The proteolytic activity of PSH is specifically suppressed by presenilin-specific inhibitors. Known modulators of γ-secretase also modulate PSH similarly in terms of the Aβ42/Aβ40 ratio. Structural analysis reveals association of a known γ-secretase inhibitor with PSH between its two catalytic aspartate residues. These findings identify PSH as a surrogate protease for the screening of agents that may regulate the protease activity and the cleavage preference of γ-secretase.
γ-分泌酶对淀粉样前体蛋白(APP)的异常切割会导致阿尔茨海默病的发展。早老素(γ-分泌酶的催化亚基)中已鉴定出200多种疾病衍生突变,这使得调节γ-分泌酶活性成为一个潜在有吸引力的治疗机会。不幸的是,处理完整γ-分泌酶的技术挑战阻碍了调节剂的发现,因此需要一种方便的替代方法。在此我们报告,与γ-分泌酶类似,古细菌早老素同源物PSH能将底物APP C99忠实地加工成Aβ42、Aβ40和Aβ38。PSH切割产物Aβ42与Aβ40的摩尔比与γ-分泌酶的几乎相同。PSH的蛋白水解活性被早老素特异性抑制剂特异性抑制。已知的γ-分泌酶调节剂在Aβ42/Aβ40比值方面对PSH的调节作用也类似。结构分析揭示了一种已知的γ-分泌酶抑制剂在其两个催化天冬氨酸残基之间与PSH的结合。这些发现确定PSH为一种替代蛋白酶,可用于筛选可能调节γ-分泌酶蛋白酶活性和切割偏好的药物。